/Investor DB

Selvedge Venture

Venture capital

London · Pre-Seed–Series A · 3 people tracked

Find your way into Selvedge Venture

1,052 people in our graph share verified history with the Selvedge Venture team — schools, employers, funds. One of them is your warm intro.

Jonathan Milnerunlockedknows Robert Thong · together at Repositive (overlapped)
×2knows the team · via Ellison Institute of Technology Oxford
knows the team · via Panacea Innovation
knows the team · via Phizz Rx Ltd ('Pharma Business Prescription')
knows the team · via Multiomic Health
knows the team · via Mubadala Capital
✨ Fox Verdict
Sign up to see your fit

Investment thesis

Selvedge Venture pursues impact investing aimed at alleviating the healthcare burden caused by age-related medical conditions, which it notes account for over 60% of loss of human life. The firm concentrates on three condition areas: metabolic syndrome (including cardiovascular disease, diabetes, fatty liver disease and obesity), cancer and neurodegenerative diseases, each carrying a large burden of excess deaths and healthcare spend. Its core expertise sits at the intersection of biotechnology and digital technologies, leveraging biotech, machine learning tools and integrated data assets to shape healthcare and life sciences. It backs pre-seed, seed and Series A ready companies.

Source: firm website, verified Sep 26, 2026.

What founders say

No founder feedback on Selvedge Venture yet.

Stage
Pre-Seed–Series A
HQ
London, GB
Instruments
Equity
Founded
2021
Last 12 months
1 investment
Tracked investments
25

Team · 3 people

from the firm's website

Founder mafia

3 people who came through Selvedge Venture went on to found or lead other companies.

What they invest in

from 15 of 25 portfolio companies

Biotech ×12AI & Machine Learning ×7Healthtech ×7Deep Tech ×4Digital Health ×4EdTech ×4Medical Devices ×4Impact & Social Good ×3

HQs:United Kingdom×6United States×5Denmark×1

Who they back

founder profiles across 6 portfolio companies

Accelerator rootsportfolio companies that came through a program

Entrepreneur First ×2

Investments · 25 tracked

founders shown can be your intro path

By year:2026 · 12023 · 12022 · 12021 · 14 dated

Alcolasealcolase.cominSeed · May 2026 · $2M

Alcolase is a biotech company developing science-based solutions for people with alcohol intolerance, a genetic condition affecting hundreds of millions of people, particularly in East Asia.

BiotechConsumerWellness & FitnessCopenhagen, DK

Mikkel Precht(Founder)in

Co-investorsAda VenturesAntlerAntler AustraliaDelphinus Venture CapitalElmehøj Ventures

Avro Life Scienceselvedgeventure.co.uk

Selvedge Venture is a venture capital firm that invests in Pre-Seed, Seed and Series A startups working to address age-related medical conditions, focusing on metabolic syndrome, cancer and neurodegenerative diseases.

AI & Machine LearningBiotechHealthtech

BIOS Healthbios.healthin𝕏Jun 2023

BIOS develops neural digital therapy technology to deliver treatments for neurological conditions.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Oliver Armitage(Founder)inEmil Hewage(Founder/Director)in

Co-investorsFifty YearsFOUNDER.orgHeuristic Capital PartnersKern Venture GroupThe Venture CollectiveY Combinator+6 more

Bob Langermit.edu𝕏

MIT is an educational and research institution in Cambridge, Massachusetts, pursuing teaching, research, and innovation across science, engineering, and other fields.

BiotechEdTechCambridge, US

Co-investorsBeyond Earth VenturesFlagship PioneeringFoundersX VenturesJIMCOLair East LabsMassChallenge Mexico

Carbometricscarbometrics.comin

Carbometrics is developing i-CAM, a continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits used in medical procedures.

HardwareHealthtechMedical Devices

Co-investorsAda VenturesScience Creates Ventures

Exogeneexogene.co.ukSeed · Apr 2022 · $2M

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Federico Paoletti(CEO & Co-Founder)inAndrea Mambrini(CTO & Co-Founder)in

Co-investorsEntrepreneur FirstJude GomilaUnruly CapitalCambridge Angels groupNadav RosenbergR42 Group

Kytopenkytopen.comin

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.

BiotechDeep TechHardwareCambridge, US

Cullen Buie(Founder; Board Observer)inPaulo Garcia(Founder)inMichael Chiu(Chief Executive Officer)in

BoardPaxton Major(Director)inAnn DeWitt(Director)inPaul Wotton(Director)

Co-investorsBantam GroupHorizons VenturesMassVenturesTBD AngelsTelegraph Hill PartnersThe Engine Ventures+2 more

Labcentrallabcentral.orgin𝕏

LabCentral is an incubator and shared laboratory facility for early-stage life science startups, offering wet lab space, core facilities, business support programs, and a network of scientific and entrepreneurial resources.

BiotechDeep TechImpact & Social GoodCambridge, US

Mesh Biomeshbio.comin

DARA's Result Interpretation Module provides a digitalized workflow that replaces manual document handling processes for specialists, eliminating printing, scanning, email distribution, and courier services in healthcare result management.

AI & Machine LearningBiotechDigital HealthHealthtech

Dr Andrew Wu(Co-Founder and CEO)Arsen Batagov(Co-Founder)in

Co-investorsElev8.vc

Multiomic Healthmultiomic.healthin

Multiomic Health applies systems biology and data science to omics datasets for drug discovery and development in cardiometabolic and related diseases, working through R&D partnerships with biopharma organizations.

AI & Machine LearningBiotechDigital HealthLondon, GB

Robert Thong(Co-founder & CEO)inAlasdair Thong(Co-founder & Non-Executive Director)inCelia Schell(Chief Clinical Officer & Chief Operating Officer)inMichael Sierra(Chief Scientific Officer)inAriella Cohain(Chief Technology Officer)inEsra Berkol(Chief of Staff)in

Co-investorsFifty YearsHoxton VenturesMMC VenturesVerve VenturesAda Ventures

Nsfnsf.govin𝕏

The U.S.

AI & Machine LearningDeep TechEdTechGovTechImpact & Social GoodArlington, US

Ochreochre.bio

Liver transplant and drug testing

Co-investorsah! VenturesKhosla VenturesLifeforce CapitalNorrsken VC

Ochre Bioochre-bio.comin𝕏

Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.

AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB

Quin Wills(Founder/CSO)inJack O'Meara(Founding CEO)in

BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle

Co-investorsBackedBeast VenturesCoastCapEntrepreneur FirstExpaHoxton Ventures+15 more

Oxford Medical Productsoxfordmedicalproducts.cominSeed · Mar 2021 · $2M

Oxford Medical Products develops medical devices, drawing on a team of biotech entrepreneurs, material scientists, polymer chemists and medical device engineers.

BiotechDigital HealthHealthtechMedical DevicesOxford, GB

Co-investorsOxford Investment Opportunity Network (OION)Ada Ventures

Rscrsc.orgin

The Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications.

BiotechClimate TechEdTechEnergyImpact & Social GoodMedia & EntertainmentLondon, GB

Thomas Graham(First President)

Wileywiley.comin𝕏

Wiley is a publishing and digital solutions company that provides content, tools, and services to academic institutions, research libraries, government agencies, healthcare systems, and journal publishers.

Data & InfrastructureEdTechEnterprise SoftwareMedia & Entertainment

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AvroBiosKytoMesBioOxford MedicalPharmaPharma CCXSanomeYuri

Portfolio news

latest coverage across their companies

Principals & officers · per Companies House

what is this? ⓘ
Alasdair Robert Thong

Director · British · since 2021

Robert Vee-Lin Thong

Director · British · since 2021

Ownership & control

Robert Thong — 25–50% of shares, 25–50% of voting rights

Alasdair Robert Thong — 25–50% of shares, 25–50% of voting rights

Selvedge Innovation Llp — 75–100% of shares, 75–100% of voting rights

Frequently asked questions

How many investments has Selvedge Venture made?
Selvedge Venture has 25 tracked investments, including 1 dated in the last 24 months.
What stage does Selvedge Venture invest at?
Selvedge Venture invests at the Pre-Seed, Seed, Series A stages.
What sectors does Selvedge Venture focus on?
Selvedge Venture focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Fintech, Healthtech, Impact & Social Good, Longevity, Medical Devices, Space Tech.
Where is Selvedge Venture located?
Selvedge Venture is headquartered in London, GB.
Who does Selvedge Venture co-invest with?
Selvedge Venture most often shares deals with Entrepreneur First, Hoxton Ventures, Flagship Pioneering, among 28 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Project Astra | Exploring the Capabilities of a Universal AI Assistant

Google · Alasdair Thong

Images

Selvedge Venture photo

Co-investors · 2

Ada Ventures

Ada Ventures is a venture capital firm that backs early-stage founders, offering support such as back-up childcare, founder welfare resources, a growth specialist for sales and go-to-market, and a dedicated talent partner to help build teams.

$317.5K – $1.3M
Cambridge Angels group

Cambridge Angels is a UK business angel network that has been providing capital and operational support to entrepreneurs since 2001, backing more than 150 companies.

Both backed · 1
$195K – $1.9M

Firms observed investing alongside Selvedge Venture, from public investor directories. Shared companies are the overlap with Selvedge Venture's recorded portfolio.

Similar investors

Featured in lists